Mercy, the U.S. health system, is applying product development principles to one of healthcare's most persistent problems: getting patients to the right care at the right time. According to a report by Healthcare IT News, the organization treats care navigation not as an operational afterthought but as a product problem — one that benefits from the same discipline product managers bring to software.

The core of the approach is straightforward. Patients often fail to reach the care they need because the path to it is fragmented: unclear next steps, handoffs between departments that drop context, and intake processes designed around institutional convenience rather than patient decision-making. Mercy's response has been to bring product thinking — defined problems, iterative delivery, and measurable outcomes — to how those care paths get designed.

For product managers outside healthcare, the significance is less the specific clinical workflows than the transferability of the pattern. Care navigation is a classic discovery-to-delivery funnel: a patient with a need (the demand), a set of services (the supply), and a matching process in between that leaks users at every stage. Any PM who has worked on onboarding, activation, or routing problems will recognize the shape of it.

What makes healthcare a harder version of this problem is the cost of a failed match. In a consumer app, a user who abandons a funnel churns and can sometimes be reacquired. In a health system, a patient who never reaches the right specialist may not get a second chance at an accurate diagnosis. That asymmetry changes how you prioritize: reducing drop-off between referral and appointment is not a growth metric, it is an outcomes metric.

The report frames Mercy's work as an example of how product development principles — rather than pure technology procurement — drive results in provider organizations. That distinction matters for PMs watching the healthcare sector. Health systems have historically bought platforms and expected transformation. Organizations that instead build internal product capability, with product owners accountable for patient journeys end to end, tend to get better returns on the same underlying technology investments.

There are honest limits to the analogy. Clinical environments impose constraints most software products never face: regulatory requirements around patient data, liability considerations in every recommendation, and clinicians whose workflows cannot be redesigned on a sprint cadence. A care-navigation "product" that optimizes for throughput at the expense of clinical judgment fails — and fails in ways that carry legal and human consequences. The framework works only when product decisions remain subordinate to clinical safety, with clinicians as stakeholders who hold veto power, not just advisory seats.

The failure mode to watch in any port of product methods into a regulated domain is metric capture: when the team starts optimizing the number that is easiest to measure (appointments booked, calls handled) rather than the outcome that matters (patients receiving appropriate care). Mercy's framing — patients reaching the care they need — points at the harder, correct metric.

The broader signal for the profession is that product management is spreading beyond software companies into service-intensive industries — healthcare, insurance, public services — where the unit of delivery is a human interaction rather than a release. As that shift continues, PMs who can operate under clinical, legal, and ethical constraints without abandoning iterative delivery will be in increasing demand.